148 related articles for article (PubMed ID: 28663761)
1. Clinical outcome of cardiac resynchronization therapy in dilated-phase hypertrophic cardiomyopathy.
Gu M; Jin H; Hua W; Fan XH; Niu HX; Tian T; Ding LG; Wang J; Xue C; Zhang S
J Geriatr Cardiol; 2017 Apr; 14(4):238-244. PubMed ID: 28663761
[TBL] [Abstract][Full Text] [Related]
2. The clinical outcome of cardiac resynchronization therapy in post-surgical valvular cardiomyopathy.
Leyva F; Umar F; Taylor RJ; Steeds RP; Frenneaux MP
Europace; 2016 May; 18(5):732-8. PubMed ID: 26802014
[TBL] [Abstract][Full Text] [Related]
3. Differential outcome of cardiac resynchronization therapy in ischemic cardiomyopathy and idiopathic dilated cardiomyopathy.
McLeod CJ; Shen WK; Rea RF; Friedman PA; Hayes DL; Wokhlu A; Webster TL; Wiste HJ; Hodge DO; Bradley DJ; Hammill SC; Packer DL; Cha YM
Heart Rhythm; 2011 Mar; 8(3):377-82. PubMed ID: 21070886
[TBL] [Abstract][Full Text] [Related]
4. Left ventricular midwall fibrosis as a predictor of mortality and morbidity after cardiac resynchronization therapy in patients with nonischemic cardiomyopathy.
Leyva F; Taylor RJ; Foley PW; Umar F; Mulligan LJ; Patel K; Stegemann B; Haddad T; Smith RE; Prasad SK
J Am Coll Cardiol; 2012 Oct; 60(17):1659-67. PubMed ID: 23021326
[TBL] [Abstract][Full Text] [Related]
5. Cardiac resynchronization therapy in patients with end-stage hypertrophic cardiomyopathy.
Killu AM; Park JY; Sara JD; Hodge DO; Gersh BJ; Nishimura RA; Asirvatham SJ; McLeod CJ
Europace; 2018 Jan; 20(1):82-88. PubMed ID: 29315424
[TBL] [Abstract][Full Text] [Related]
6. Difference in myocardial flow reserve between patients with dilated cardiomyopathy and those with dilated phase of hypertrophic cardiomyopathy: evaluation by 15O-water PET.
Ohba M; Hosokawa R; Kambara N; Tadamura E; Mamede M; Kubo S; Yamamuro M; Fujita M; Kimura T; Nohara R; Kita T
Circ J; 2007 Jun; 71(6):884-90. PubMed ID: 17526985
[TBL] [Abstract][Full Text] [Related]
7. Echocardiography-guided left ventricular lead placement for cardiac resynchronization therapy in ischemic vs nonischemic cardiomyopathy patients.
Abu Daya H; Alam MB; Adelstein E; Schwartzman D; Jain S; Marek J; Gorcsan J; Saba S
Heart Rhythm; 2014 Apr; 11(4):614-9. PubMed ID: 24462657
[TBL] [Abstract][Full Text] [Related]
8. Long-term outcomes of cardiac resynchronization therapy in adult congenital heart disease.
Leyva F; Zegard A; Qiu T; de Bono J; Thorne S; Clift P; Marshall H; Hudsmith L
Pacing Clin Electrophysiol; 2019 Jun; 42(6):573-580. PubMed ID: 30908673
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of cardiac resynchronization therapy by the frequency of revascularization procedures in ischemic cardiomyopathy patients.
Husaini M; Biton Y; Stair B; Moss AJ; Biering-Sørensen T; Solomon S; McNitt S; Polonsky B; Zareba W; Barsheshet A; Kutyifa V
Cardiol J; 2016; 23(4):437-45. PubMed ID: 27320956
[TBL] [Abstract][Full Text] [Related]
10. Long-term clinical outcomes of cardiac resynchronization therapy with or without defibrillation: impact of the aetiology of cardiomyopathy.
Leyva F; Zegard A; Umar F; Taylor RJ; Acquaye E; Gubran C; Chalil S; Patel K; Panting J; Marshall H; Qiu T
Europace; 2018 Nov; 20(11):1804-1812. PubMed ID: 29697764
[TBL] [Abstract][Full Text] [Related]
11. Response to preventive cardiac resynchronization therapy in patients with ischaemic and nonischaemic cardiomyopathy in MADIT-CRT.
Barsheshet A; Goldenberg I; Moss AJ; Eldar M; Huang DT; McNitt S; Klein HU; Hall WJ; Brown MW; Goldberger JJ; Goldstein RE; Schuger C; Zareba W; Daubert JP
Eur Heart J; 2011 Jul; 32(13):1622-30. PubMed ID: 21075774
[TBL] [Abstract][Full Text] [Related]
12. Tachycardia Therapy Outcomes of Ischemic Versus Nonischemic Cardiomyopathy on Cardiac Resynchronization Therapy: A Propensity Score-matched Analysis.
Malik J; Awais M; Shabbir M; Rauf A; Zaffar S; Hayat A; Mehmoodi A
J Community Hosp Intern Med Perspect; 2023; 13(6):83-89. PubMed ID: 38596550
[TBL] [Abstract][Full Text] [Related]
13. Profound differences in prognostic impact of left ventricular reverse remodeling after cardiac resynchronization therapy relate to heart failure etiology.
Martens P; Nijst P; Verbrugge FH; Dupont M; Tang WHW; Mullens W
Heart Rhythm; 2018 Jan; 15(1):130-136. PubMed ID: 28843420
[TBL] [Abstract][Full Text] [Related]
14. Right ventricular myocardial function in patients with either idiopathic or ischemic dilated cardiomyopathy without clinical sign of right heart failure: effects of cardiac resynchronization therapy.
D'Andrea A; Salerno G; Scarafile R; Riegler L; Gravino R; Castaldo F; Cocchia R; Limongelli G; Romano M; Calabrò P; Nigro G; Cuomo S; Bossone E; Caso P; Calabrò R
Pacing Clin Electrophysiol; 2009 Aug; 32(8):1017-29. PubMed ID: 19659622
[TBL] [Abstract][Full Text] [Related]
15. Predictive Factors for Decreasing Left Ventricular Ejection Fraction and Progression to the Dilated Phase of Hypertrophic Cardiomyopathy.
Ishihara K; Kubota Y; Matsuda J; Imori Y; Tokita Y; Asai K; Takano H
J Clin Med; 2023 Aug; 12(15):. PubMed ID: 37568539
[TBL] [Abstract][Full Text] [Related]
16. Adding Defibrillation Therapy to Cardiac Resynchronization on the Basis of the Myocardial Substrate.
Barra S; Boveda S; Providência R; Sadoul N; Duehmke R; Reitan C; Borgquist R; Narayanan K; Hidden-Lucet F; Klug D; Defaye P; Gras D; Anselme F; Leclercq C; Hermida JS; Deharo JC; Looi KL; Chow AW; Virdee M; Fynn S; Le Heuzey JY; Marijon E; Agarwal S;
J Am Coll Cardiol; 2017 Apr; 69(13):1669-1678. PubMed ID: 28359511
[TBL] [Abstract][Full Text] [Related]
17. Atrioventricular delay programming and the benefit of cardiac resynchronization therapy in MADIT-CRT.
Brenyo A; Kutyifa V; Moss AJ; Mathias A; Barsheshet A; Pouleur AC; Knappe D; McNitt S; Polonsky B; Huang DT; Solomon SD; Zareba W; Goldenberg I
Heart Rhythm; 2013 Aug; 10(8):1136-43. PubMed ID: 23712031
[TBL] [Abstract][Full Text] [Related]
18. Analysis of circulating apoptosis mediators and proinflammatory cytokines in patients with idiopathic hypertrophic cardiomyopathy: comparison between nonobstructive and dilated-phase hypertrophic cardiomyopathy.
Zen K; Irie H; Doue T; Takamiya M; Yamano T; Sawada T; Azuma A; Matsubara H
Int Heart J; 2005 Mar; 46(2):231-44. PubMed ID: 15876807
[TBL] [Abstract][Full Text] [Related]
19. A cohort study of cardiac resynchronization therapy in patients with chronic Chagas cardiomyopathy.
Martinelli Filho M; de Lima Peixoto G; de Siqueira SF; Martins SAM; Nishioka SAD; Pedrosa AAA; Teixeira RA; Dos Santos JX; Costa R; Kalil Filho R; Ramires JAF
Europace; 2018 Nov; 20(11):1813-1818. PubMed ID: 29509903
[TBL] [Abstract][Full Text] [Related]
20. The association of hematological indices with the response to cardiac resynchronization therapy: a single-center study.
Bazoukis G; Saplaouras A; Letsas KP; Yeung C; Xydonas S; Karamichalakis N; Thomopoulos C; Manolatos D; Papathanakos G; Vlachos K; Tse G; Korantzopoulos P; Efremidis M; Sideris A; Naka KK
Hippokratia; 2019; 23(3):118-125. PubMed ID: 32581497
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
